BIO REFERENCE LABORATORIES INC
Healthcare · Services-Medical Laboratories · NJ · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Operating income | $83.4M | $82.0M | $76.1M | $59.8M | $48.4M |
| Net income | — | — | — | — | — |
| Total assets | $478.9M | $421.5M | $312.8M | $283.3M | $244.1M |
| Total liabilities | — | — | — | — | — |
| Equity | $318.9M | $271.6M | $227.2M | $189.8M | $152.4M |
| EPS (diluted) | $0.11 | $0.31 | $0.26 | $0.28 | $0.14 |
| Shares out. | 27.7M | 27.7M | 27.9M | 27.9M | 27.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- —
- Net margin
- —
- Return on equity
- —
- Return on assets
- —
- Return on capital (ROCE)
- 25.0%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $11.51
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Jan 30, 2001
- NT 10-Qmissed a reporting deadline ↗Sep 14, 1999
- NT 10-Qmissed a reporting deadline ↗Jun 14, 1999
- NT 10-Qmissed a reporting deadline ↗Mar 17, 1999
- NT 10-Kmissed a reporting deadline ↗Jan 29, 1999
- NT 10-Qmissed a reporting deadline ↗Sep 14, 1998
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · New financial obligation · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Shareholder voteAug 20, 2015
- Other material eventAug 10, 2015
- Results of operationsJun 11, 2015
- Regulation FD disclosure · Other material eventJun 10, 2015
- Other material eventJun 8, 2015
- Results of operationsJun 8, 2015
- Entered a material agreement · Director / officer change · Other material eventJun 4, 2015
- Entered a material agreementMay 20, 2015
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GAug 31, 2015
- 8-KFORM 8-KAug 20, 2015
- S-8 POSAug 20, 2015
- 4FORM 4Aug 20, 2015
- 4FORM 4Aug 20, 2015
- 4FORM 4Aug 20, 2015
- 4FORM 4Aug 20, 2015
- 25-NSEAug 20, 2015
- 425Aug 19, 2015
- 8-KFORM 8-KAug 10, 2015
- 425Aug 6, 2015
- 425Jul 30, 2015
- DEFM14AJul 20, 2015
- 425FORM 8-KJul 2, 2015
- 425FORM 425Jul 2, 2015